Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms, Plasma Cell × Vinorelbine × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 19 Carcinoma, Non-Small-Cell Lung 7 Triple Negative Breast Neoplasms 4 Rhabdomyosarcoma 4 Hodgkin Disease 4 Recurrence 3 Uterine Cervical Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Adenocarcinoma 2 Solitary Fibrous Tumor, Pleural 1 Sarcoma 1 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 NSCLC 1 Mesothelioma, Malignant 1 Lung Diseases, Interstitial 1 Locally Advanced Non-Small Cell Lung Cancer 1 HR+HER2- Breast Cancer 1 HER2-negative Metastatic Breast Cancer 1 Fludzoparib" and Anti-angiogenic 1 Desmoplastic Small Round Cell Tumor 1 Colonic Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Large Cell 1 Advanced Breast Cancer 1

Interventions

Dexamethasone 16 Lenalidomide 12 Bortezomib 9 Cyclophosphamide 7 carfilzomib 6 Whole-Body Irradiation 6 Melphalan 6 fludarabine 5 daratumumab 5 Tacrolimus 5 Mycophenolic Acid 5 Calcium Dobesilate 5 pomalidomide 3 fludarabine phosphate 3 belantamab mafodotin 3 Radiotherapy 3 gamma-Globulins 2 elotuzumab 2 Trimethoprim, Sulfamethoxazole Drug Combination 2 Sirolimus 2 Prednisone 2 Immunoglobulins, Intravenous 2 Hematopoietic Stem Cell Transplantation 2 Etoposide 2 venetoclax 1 thymoglobulin 1 siltuximab 1 poly ICLC 1 pembrolizumab 1 ixazomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡